| Primary |
| Attention Deficit/hyperactivity Disorder |
55.6% |
| Narcolepsy |
11.1% |
| Add |
5.6% |
| Agitation |
5.6% |
| Drug Abuse |
5.6% |
| Jitteriness |
5.6% |
| Product Used For Unknown Indication |
5.6% |
| Substance Abuse |
5.6% |
|
| Toxicity To Various Agents |
20.7% |
| Product Substitution Issue |
13.8% |
| Somnolence |
6.9% |
| Cerebral Artery Occlusion |
3.4% |
| Fear |
3.4% |
| Feeling Jittery |
3.4% |
| Impaired Work Ability |
3.4% |
| Metabolic Acidosis |
3.4% |
| Nausea |
3.4% |
| Pupillary Reflex Impaired |
3.4% |
| Sensation Of Heaviness |
3.4% |
| Slow Speech |
3.4% |
| Sudden Death |
3.4% |
| Therapeutic Response Unexpected With Drug Substitution |
3.4% |
| Tongue Disorder |
3.4% |
| Urinary Tract Infection |
3.4% |
| Vaginal Haemorrhage |
3.4% |
| Vascular Graft |
3.4% |
| Vision Blurred |
3.4% |
| Withdrawal Syndrome |
3.4% |
|
| Secondary |
| Product Used For Unknown Indication |
60.5% |
| Drug Abuse |
23.0% |
| Drug Use For Unknown Indication |
4.4% |
| Suicide Attempt |
3.1% |
| Ill-defined Disorder |
1.1% |
| Substance Abuse |
1.0% |
| Attention Deficit/hyperactivity Disorder |
0.9% |
| Schizophrenia |
0.8% |
| Depression |
0.6% |
| Foetal Exposure During Pregnancy |
0.6% |
| Pain |
0.6% |
| Depressive Disorder |
0.5% |
| Bipolar I Disorder |
0.4% |
| Cardiac Disorder |
0.4% |
| Completed Suicide |
0.4% |
| Drug Abuser |
0.4% |
| Rheumatoid Arthritis |
0.4% |
| Basedow's Disease |
0.3% |
| Blood Cholesterol Increased |
0.3% |
| Psychotic Disorder |
0.3% |
|
| Toxicity To Various Agents |
19.5% |
| Completed Suicide |
17.1% |
| Respiratory Arrest |
14.3% |
| Drug Abuse |
8.6% |
| Death |
6.7% |
| Poisoning |
6.7% |
| Overdose |
5.7% |
| Intentional Drug Misuse |
4.8% |
| Substance Abuse |
2.4% |
| Accidental Overdose |
1.9% |
| Drug Toxicity |
1.9% |
| Serotonin Syndrome |
1.4% |
| Suicide Attempt |
1.4% |
| Tachycardia |
1.4% |
| Wrong Technique In Drug Usage Process |
1.4% |
| Cardio-respiratory Arrest |
1.0% |
| Drug Hypersensitivity |
1.0% |
| Fatigue |
1.0% |
| Intentional Overdose |
1.0% |
| Multiple Drug Overdose |
1.0% |
|
| Concomitant |
| Product Used For Unknown Indication |
31.5% |
| Depression |
11.3% |
| Attention Deficit/hyperactivity Disorder |
8.3% |
| Accidental Exposure |
6.0% |
| Bipolar Disorder |
6.0% |
| Insomnia |
4.8% |
| Pain |
4.2% |
| Anxiety |
3.0% |
| Multiple Sclerosis |
3.0% |
| Sleep Disorder |
3.0% |
| Fatigue |
2.4% |
| Gastrooesophageal Reflux Disease |
2.4% |
| Breast Cancer |
1.8% |
| Contraception |
1.8% |
| Cough |
1.8% |
| Disturbance In Attention |
1.8% |
| Diuretic Therapy |
1.8% |
| Drug Abuser |
1.8% |
| Drug Use For Unknown Indication |
1.8% |
| Neuropathy Peripheral |
1.8% |
|
| Overdose |
8.8% |
| Ventricular Tachycardia |
8.8% |
| Vomiting |
8.8% |
| Weight Decreased |
8.8% |
| Fluid Retention |
5.9% |
| Injection Site Reaction |
5.9% |
| Papilloedema |
5.9% |
| Sinus Tachycardia |
5.9% |
| Weight Increased |
5.9% |
| Wrong Technique In Drug Usage Process |
5.9% |
| Abnormal Palmar/plantar Creases |
2.9% |
| Accidental Overdose |
2.9% |
| Cerebrovascular Accident |
2.9% |
| Clonus |
2.9% |
| Death |
2.9% |
| Deep Vein Thrombosis |
2.9% |
| Depressed Mood |
2.9% |
| Depression |
2.9% |
| Drug Effect Decreased |
2.9% |
| Fatigue |
2.9% |
|
| Interacting |
| Product Used For Unknown Indication |
100.0% |
|
| Hepatitis C |
40.0% |
| Toxicity To Various Agents |
40.0% |
| Drug Interaction |
20.0% |
|
